Literature DB >> 16454719

Combination therapy in fibromyalgia.

A H Clayton1, S G West.   

Abstract

Fibromyalgia is an enigmatic medical condition whose specific etiology remains undiscovered but currently plagues five million Americans. Research indicates that the origin of the disease is most likely multifactorial. Treatment should therefore be tailored accordingly. Thus, it is often necessary to combine different options in order to achieve the maximum benefit in patients suffering from fibromyalgia.

Entities:  

Mesh:

Year:  2006        PMID: 16454719

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Trazodone for the treatment of fibromyalgia: an open-label, 12-week study.

Authors:  Piedad Morillas-Arques; Carmen Ma Rodriguez-Lopez; Rocio Molina-Barea; Fernando Rico-Villademoros; Elena P Calandre
Journal:  BMC Musculoskelet Disord       Date:  2010-09-10       Impact factor: 2.362

2.  Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study.

Authors:  Elena P Calandre; Piedad Morillas-Arques; Rocío Molina-Barea; Carmen M Rodriguez-Lopez; Fernando Rico-Villademoros
Journal:  BMC Musculoskelet Disord       Date:  2011-05-16       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.